Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Shu Wei Ting

Showing results (1-10 of 132) with videos related to

Pageof 14
Sort By:
Ophthalmology|June 18, 2026
From Consensus to Regulatory End Point: Establishing Reference Standards as a Critical Step for Artificial Intelligence Software as Medical DevicesDaniel Shu Wei Ting
The Lancet. Global Health|January 26, 2023
AI telemedicine screening in ophthalmology: health economic considerationsZhen Ling Teo, Daniel Shu Wei Ting
Nature Medicine|January 23, 2023
Non-fungible tokens for the management of health dataZhen Ling Teo, Daniel Shu Wei Ting
Nature Biomedical Engineering|April 25, 2019
Eyeing cardiovascular risk factorsDaniel Shu Wei Ting, Tien Yin Wong
Ophthalmology. Retina|August 6, 2022
Federated Learning in Ophthalmology: Retinopathy of PrematurityZhen Ling Teo, Daniel Shu Wei Ting
Nature Biomedical Engineering|April 12, 2022
Eyeing severe diabetes upfrontZhen Ling Teo, Daniel Shu Wei Ting
Lancet (London, England)|May 13, 2017
Proliferative diabetic retinopathy: laser or eye injection?Daniel Shu Wei Ting, Tien Yin Wong
JAMA Ophthalmology|May 19, 2017
Telemedicine for Diabetic Retinopathy ScreeningDaniel Shu Wei Ting, Gavin Siew Wei Tan
Annals of the Academy of Medicine, Singapore|December 20, 2025
Augmented intelligence: An emerging paradigm for AI in healthcareWilliam Ying Khee Hwang, Daniel Shu Wei Ting
Frontiers in Endocrinology|April 20, 2023
Editorial: Ocular complications associated with diabetes mellitusXinyuan Zhang, Sobha Sivaprasad, Daniel Shu Wei Ting
Pageof 14

Showing results (1-10 of 132) with videos related to

Sort By:
Pageof 14
Ophthalmology|June 18, 2026
From Consensus to Regulatory End Point: Establishing Reference Standards as a Critical Step for Artificial Intelligence Software as Medical DevicesDaniel Shu Wei Ting
The Lancet. Global Health|January 26, 2023
AI telemedicine screening in ophthalmology: health economic considerationsZhen Ling Teo, Daniel Shu Wei Ting
Nature Medicine|January 23, 2023
Non-fungible tokens for the management of health dataZhen Ling Teo, Daniel Shu Wei Ting
Nature Biomedical Engineering|April 25, 2019
Eyeing cardiovascular risk factorsDaniel Shu Wei Ting, Tien Yin Wong
Ophthalmology. Retina|August 6, 2022
Federated Learning in Ophthalmology: Retinopathy of PrematurityZhen Ling Teo, Daniel Shu Wei Ting
Nature Biomedical Engineering|April 12, 2022
Eyeing severe diabetes upfrontZhen Ling Teo, Daniel Shu Wei Ting
Lancet (London, England)|May 13, 2017
Proliferative diabetic retinopathy: laser or eye injection?Daniel Shu Wei Ting, Tien Yin Wong
JAMA Ophthalmology|May 19, 2017
Telemedicine for Diabetic Retinopathy ScreeningDaniel Shu Wei Ting, Gavin Siew Wei Tan
Annals of the Academy of Medicine, Singapore|December 20, 2025
Augmented intelligence: An emerging paradigm for AI in healthcareWilliam Ying Khee Hwang, Daniel Shu Wei Ting
Frontiers in Endocrinology|April 20, 2023
Editorial: Ocular complications associated with diabetes mellitusXinyuan Zhang, Sobha Sivaprasad, Daniel Shu Wei Ting
Pageof 14